BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14504023)

  • 1. Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations.
    Granholm E; Anthenelli R; Monteiro R; Sevcik J; Stoler M
    Am J Addict; 2003; 12(4):306-13. PubMed ID: 14504023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders.
    Ilgen MA; Hu KU; Moos RH; McKellar J
    Psychiatr Serv; 2008 Sep; 59(9):982-8. PubMed ID: 18757590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of comorbid substance and alcohol use disorders to disability among patients in routine psychiatric practice.
    Wilk J; West JC; Rae DS; Regier DA
    Am J Addict; 2006; 15(2):180-5. PubMed ID: 16595357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of case manager ratings and weekly urine toxicology tests among outpatients with dual diagnoses.
    Ries RK; Dyck DG; Short R; Srebnik D; Snowden M; Comtois KA
    Psychiatr Serv; 2002 Jun; 53(6):764-6. PubMed ID: 12045318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission.
    Swindle RW; Phibbs CS; Paradise MJ; Recine BP; Moos RH
    J Subst Abuse; 1995; 7(1):79-97. PubMed ID: 7655313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Music therapy: a novel motivational approach for dually diagnosed patients.
    Ross S; Cidambi I; Dermatis H; Weinstein J; Ziedonis D; Roth S; Galanter M
    J Addict Dis; 2008; 27(1):41-53. PubMed ID: 18551887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
    Hopko DR; Lachar D; Bailley SE; Varner RV
    Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders.
    Irmiter C; Barry KL; Cohen K; Blow FC
    Subst Abus; 2009; 30(1):40-6. PubMed ID: 19197780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder.
    Bauer MS; Altshuler L; Evans DR; Beresford T; Williford WO; Hauger R;
    J Affect Disord; 2005 Apr; 85(3):301-15. PubMed ID: 15780700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing disability benefits as part of treatment for persons with severe mental illness and comorbid drug/alcohol disorders. A comparative study of payee and non-payee participants.
    Ries RK; Comtois KA
    Am J Addict; 1997; 6(4):330-8. PubMed ID: 9398931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assertive community treatment in the Netherlands: a randomized controlled trial.
    Sytema S; Wunderink L; Bloemers W; Roorda L; Wiersma D
    Acta Psychiatr Scand; 2007 Aug; 116(2):105-12. PubMed ID: 17650271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of integrated dual disorders treatment: a qualitative analysis of facilitators and barriers.
    Brunette MF; Asher D; Whitley R; Lutz WJ; Wieder BL; Jones AM; McHugo GJ
    Psychiatr Serv; 2008 Sep; 59(9):989-95. PubMed ID: 18757591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assertive community treatment for the seriously mentally ill in suburban Sydney: a programme description and evaluation.
    Hambridge JA; Rosen A
    Aust N Z J Psychiatry; 1994 Sep; 28(3):438-45. PubMed ID: 7893238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.